EASL nonalcoholic fatty liver disease summit: uniting clinicians, experts, and industry
7 recent reports on obesity risks in liver disease, lifestyle intervention
Existing liver drug can help treat alzheimer’s
EASL mourns the passing of Professor Jan De Groote
New target could prevent progression of liver damage to cancer
Photo caption: Dr. Anatolij Horuzsko, reproductive immunologist in the Georgia Cancer Center and Department of Medicine at the Medical College of Georgia at Augusta University (photo credit: Phil Jones, Senior Photographer, Augusta University) Problems like obesity and alcoholism appear to…
More protein after weight loss may reduce fatty liver disease
Increasing the amount of protein in the diet may reduce the liver's fat content and lower the risk of diabetes in people with nonalcoholic fatty liver disease (NAFLD). The study is published ahead of print in the American Journal of…
Even light drinking may make fatty liver disease worse
New drug may improve liver cancer therapy
The LANCET-EASL Commission on liver diseases in Europe: Overcoming unmet needs, stigma, and inequities
Worldwide, liver diseases are on the rise, yet patients with liver disease are still experiencing stigma, resulting in a barrier to liver disease awareness and inequity in access to appropriate care. The Lancet–EASL Commission will identify key challenges and opportunities for tackling…